Rapid Therapeutic Science Laboratories, Inc. (RTSL)

OTCMKTS: RTSL · Delayed Price · USD
2.40
0.00 (0.00%)
Aug 16, 2022 3:33 PM - Market open
0.00%
Market Cap 18.59M
Revenue (ttm) 534
Net Income (ttm) -3.91M
Shares Out 7.75M
EPS (ttm) -0.51
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date Mar 31, 2022
Volume 5
Open 2.40
Previous Close 2.40
Day's Range 2.40 - 2.40
52-Week Range 0.27 - 12.50
Beta -13.38
Analysts n/a
Price Target n/a
Earnings Date n/a

About RTSL

Rapid Therapeutic Science Laboratories, Inc. operates as a biotech company. The company engages in the aerosol delivery of non-psychoactive cannabinoids to the blood stream for treatment of chronic pain, post-traumatic stress disorder, insomnia, surgery recovery, and other ailments. It offers pressurized meter dose inhaler, a device that delivers a measured amount of aerosolized inhalant in a mist to the lungs; sublingual oral spray devices; and water-soluble cannabidiol and cannabigerol isolates under the nhaler brand. The company was formerly... [Read more...]

Industry Medical Devices
Founded 2013
Employees 8
Stock Exchange OTCMKTS
Ticker Symbol RTSL
Full Company Profile

News

Rapid Therapeutic Science Laboratories File S1 and completes Mid-Year Strategy Review

DALLAS, July 26, 2022 (GLOBE NEWSWIRE) -- Rapid Therapeutics Science Laboratories (OTC: RTSL) ("Rapid Therapeutic'' or the "Company"), a growth-oriented aerosol manufacturing company focused on natural ...

Rapid Therapeutic Science Laboratories to Present at the Q4 Investor Summit Conference

DALLAS, Nov. 12, 2021 (GLOBE NEWSWIRE) -- Rapid Therapeutics Science Laboratories (OTC: RTSL) ("Rapid Therapeutic'' or the "Company"), a growth-oriented aerosol manufacturing company focused on delivery...

Rapid Therapeutic Science Laboratories Secures Upgraded Laboratory and Manufacturing Facility

DALLAS, Nov. 11, 2021 (GLOBE NEWSWIRE) -- Rapid Therapeutics Science Laboratories (OTC: RTSL) ("Rapid Therapeutic'' or the "Company"), a growth-oriented aerosol manufacturing company focused on delivery...